Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories (NY: BIO )

364.42 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 364.42
Bid (Size) 355.67 (1)
Ask (Size) 417.27 (1)
Prev. Close 364.42
Today's Range 364.42 - 364.42
52wk Range 344.63 - 509.62
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading
Via Investor Brand Network
3 Beaten-Down Biotech Stocks Bound for a Bounce Back
Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs. 
Via InvestorPlace

Performance

YTD
-13.73%
-13.73%
1 Month
-4.14%
-4.14%
3 Month
-0.56%
-0.56%
6 Month
-21.83%
-21.83%
1 Year
-16.68%
-16.68%

More News

Read More
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
The Latest Analyst Ratings for Bio-Rad Laboratories
Via Benzinga
Bio-Rad Reports Second-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
The Latest Analyst Ratings for Bio-Rad Laboratories
Via Benzinga
Death Cross Looms Over Bio-Rad Laboratories Investors
Via Benzinga
Recap: Bio-Rad Laboratories Q1 Earnings
Via Benzinga
Golden Cross Appears Before Bio-Rad Laboratories Investors
Via Benzinga
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
From Bio-Rad Laboratories, Inc.
Via Business Wire
Why Are velo Biosciences Stock Is Trading Higher Today?
Via Benzinga
Bio-Rad Announces New Share Repurchase Program
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
Bio-Rad Publishes Corporate Sustainability Report for 2022
From Bio-Rad Laboratories, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
Via Benzinga
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
Via Benzinga
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Stocks Roar Back To Life; Still Pacing For Weekly Loss
Via Talk Markets
Bio-Rad Reports First-Quarter 2023 Financial Results
From Bio-Rad Laboratories, Inc.
Via Business Wire
Why Atlassian Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
From Bio-Rad Laboratories, Inc.
Via Business Wire
The 3 Most Promising Biotech Stocks to Buy Now
Via InvestorPlace
I Asked ChatGPT for 10 EV Stocks to Buy. Here’s What It Recommended.
Via InvestorPlace
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
From Bio-Rad Laboratories, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.